Chinese pharmaceutical firms are plunging as a drug safety scandal spills over to become a sector-wide trust crisis.

July 23, 2018July 23, 2018 by IWB

0Shares

Authorities found Changsheng Biotechnology’s subsidiary produced substandard vaccines and forged production data. Its shares have been suspended from trading.

We truly are under attack. We need user support now more than ever! For as little as $10, you can support the IWB directly – and it only takes a minute. Thank you. 496 views